BRCA1/2 mutations may alter endometrial, ovarian function
Scientists have detected significant differences in endometrial thickness and hormone levels in women with and without BRCA1/2 mutations that may play a role in cancer susceptibility or development. (Source: MedWire News - Breast Cancer)
Source: MedWire News - Breast Cancer - October 22, 2013 Category: Cancer & Oncology Source Type: news
Gene variations predict breast cancer sleep disturbance
Researchers have identified cytokine gene variations in women with breast cancer that may help to identify those at increased risk for sleep disturbance following surgery. (Source: MedWire News - Breast Cancer)
Source: MedWire News - Breast Cancer - September 16, 2013 Category: Cancer & Oncology Source Type: news
Tamoxifen breast changes predict survival
Women with breast cancer who experience a tamoxifen-related decrease in mammographic density have significantly better survival than patients whose breast density is unaffected by the agent, suggest study findings. (Source: MedWire News - Breast Cancer)
Source: MedWire News - Breast Cancer - April 26, 2013 Category: Cancer & Oncology Source Type: news
Radiotherapy ‘does not preclude’ immediate breast reconstruction
Women who receive radiotherapy after free-flap breast reconstruction are no more likely to require revision surgery than those who do not, say US researchers who believe immediate autologous surgery is feasible in this group. (Source: MedWire News - Breast Cancer)
Source: MedWire News - Breast Cancer - April 13, 2013 Category: Cancer & Oncology Source Type: news
Copper depletion may prevent breast cancer recurrence
Early trial findings suggest that copper depletion may promote tumor dormancy in patients at high risk for recurrent breast cancer. (Source: MedWire News - Breast Cancer)
Source: MedWire News - Breast Cancer - February 19, 2013 Category: Cancer & Oncology Source Type: news
Breast cancer genes modify age at menopause
Women with the BRCA1 or BRCA2 mutation begin menopause at a significantly younger median age than noncarriers, US researchers warn. (Source: MedWire News - Breast Cancer)
Source: MedWire News - Breast Cancer - February 5, 2013 Category: Cancer & Oncology Source Type: news
MRI ‘good accuracy’ for detecting residual breast cancer
Magnetic resonance imaging is superior to mammography for the detection of residual breast cancer after neoadjuvant chemotherapy, research confirms. (Source: MedWire News - Breast Cancer)
Source: MedWire News - Breast Cancer - January 22, 2013 Category: Cancer & Oncology Source Type: news
18FDG–PET–CT improves breast cancer staging
A prospective study has shown fluorodeoxyglucose positron emission tomography/computed tomography to be a powerful tool for the detection of nodal and distant metastatic disease in patients with breast cancer. (Source: MedWire News - Breast Cancer)
Source: MedWire News - Breast Cancer - December 17, 2012 Category: Cancer & Oncology Source Type: news
Lapatinib benefits found for HER2-positive early-stage patients
Women with early-stage, HER2-positive breast cancer who are unable to use trastuzumab may benefit from adjuvant lapatinib treatment, suggest phase III trial findings published in Lancet Oncology. (Source: MedWire News - Breast Cancer)
Source: MedWire News - Breast Cancer - December 17, 2012 Category: Cancer & Oncology Source Type: news
